CO-TECHSTARS
16.11.2020 14:02:12 CET | Business Wire | Press release
Techstars, the worldwide network that helps entrepreneurs succeed, is now accepting entries for the Techstars Sustainability Challenge from anyone with ideas for how to reduce the significant toll global supply chains have on the environment. Winners will be showcased at the first Techstars Sustainability Summit in April, and at least one will have the opportunity to develop a proof-of-concept with a Techstars Sustainability Challenge Program Partner. Techstars Pathfinder members and Challenge Partners for this effort are: ABN AMRO, Cargill, Comcast NBCUNIVERSAL LIFT LABS, EG, Endeavor, Equinor, Princeton University through Princeton Innovation and the Andlinger Center for Energy and the Environment, Semapa NEXT investment company, Stanley Black & Decker, The Heritage Group, The Nature Conservancy, Temasek and World Federation of United Nations Associations (WFUNA).
The Techstars Sustainability Challenge is designed to accelerate efforts to develop new products, solutions and processes that will improve supply chain operations. Techstars and its Challenge Partners see collaborative efforts like this as critical to reducing the negative environmental impacts of supply chains and creating efficiencies that will drive long-term positive impacts for industries, markets and people around the world.
“A massive challenge in sustainability today is improving operations of the global economy’s complex supply chains to be more efficient and environmentally friendly. It’s difficult for companies to get insights into their overall footprint and the operations of their suppliers, and ultimately alter behaviors and systems,” says Cody Simms, SVP of Investments and leader of Techstars’ global sustainability programs. “Through the Techstars Sustainability Challenge, we are putting out the call to entrepreneurs, tech startups, researchers, NGOs and corporate innovators to help us find and scale solutions to one of the world’s most urgent sustainability problems. We are looking for innovators who can help build a more sustainable supply chain through their work on the measurement and management of supply chain impacts.”
Entry Categories
Innovators will submit their entries to one of two specific areas:
- Data & Automation: Solutions to help companies use automation, internal data collection, or more accurate inferences of external data sources to better measure, trace, and track the impact of their supply chain footprints.
- Materials & End-of-life Impact: Enable a manufacturer to reduce the impact of a product’s footprint through new materials innovations, either natural or synthetic. Solutions can range from limiting the extractive process for obtaining the raw materials, extending product lifespan, or mitigating the product’s end-of-life impact on the environment.
A panel of sustainability experts from Techstars along with Challenge Partners will judge all submissions on three criteria: problem-solution fit; scale of the solution’s potential impact; and the ability to implement a proof-of-concept with an enterprise organization.
Timeline
- November 16, 2020: Applications open
- March 8, 2021: Applications close
- March 25, 2021: Finalists notified
- April 1, 2021: Proof-of-Concept (POC) Working Session (virtual) - Finalists will deliver their pitches to judges, receive formal introductions to relevant corporate business units, and participate in matchmaking workshops with Founding Partners to brainstorm proof-of-concept and pilot concepts.
- April 15, 2021: Techstars Sustainability Summit Event (virtual) - Winners announced. At least one winner will have the opportunity to run a proof-of-concept with one of our Challenge Partners.
“The goal is actionable impact,” adds Simms. “The winners’ journey with Techstars won’t end in a competitive victory. We will partner them with mentors from our global participating partner network so they can immediately begin working on building out real-world solutions that will affect meaningful change.”
Building a Strong Network of Mentors and Investors
Techstars Pathfinder Membership matches corporate innovators with exactly the right startups who can turn innovative ideas into business opportunities and open new revenue streams. The ultimate goal is to speed corporate innovators to action. That can mean establishing partnerships, building proofs of concept, identifying and seizing investment opportunities, or acquiring teams, technologies and/or customers.
The Techstars Sustainability Challenge is the anchor project for bringing together a group of members in 2020 to drive real progress toward a more sustainable world.
Follow this link to enter the Techstars Sustainability Challenge. Click here to learn more about partnership opportunities.
About Techstars
The Techstars worldwide network helps entrepreneurs succeed. Founded in 2006, Techstars began with three simple ideas — entrepreneurs create a better future for everyone, collaboration drives innovation, and great ideas can come from anywhere. Now we are on a mission to enable every person on the planet to contribute to, and benefit from, the success of entrepreneurs. In addition to operating accelerator programs and venture capital funds, we do this by connecting startups, investors, corporations, and cities to help build thriving startup communities. Techstars has invested in more than 2,200 companies that today have a combined market cap valuation of more than $30 Billion. www.techstars.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005191/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom